Literature DB >> 19218625

[Occurrence of anxiety and depression disorders after acute cardiac events during hospital rehabilitation. Application of the Hospital Anxiety and Depression Scale as a screening instrument].

István Tiringer1, Attila Simon, Dóra Herrfurth, Irén Suri, Katalin Szalai, Abor Veress.   

Abstract

UNLABELLED: Hospital Anxiety and Depression Scale (HADS) is one of the most frequently used screening instruments for comorbid psychiatric disorders in patients with somatic diseases. Depression and anxiety disorders occurring after acute coronary events predict a worse prognosis and rehabilitation outcome and impair the patient's quality of life. Therefore, diagnosis and treatment of depression and anxiety are important clinical issues.
METHODS: Item characteristics, different aspects of reliability and validity of the HADS test parameters have been analysed on the basis of a follow-up study of 747 patients after acute coronary events participating in a hospital rehabilitation program. Short form of the Beck Depression Inventory, Spielberger State Anxiety Inventory, Hamilton Anxiety and Hamilton Depression Questionnaires were used as references. Criterion validity and cut-off points of HADS subscales were determined according to MINI+, a standardised diagnostic interview.
RESULTS: The Depression (D) and Anxiety (A) subscales of the Hungarian version of HADS demonstrated high internal consistency (HADS-D: Cronbach =0,81, HADS-A: =0,85). Explorative factor analysis yielded a two-factor (1st: anxiety and 2nd: depression) structure. HADS subscales have shown high correlations with scales measuring similar constructs and validated in Hungarian. Empirical cut-off points of both subscales were determined with ROC analysis (HADS-D: 9 points, HADS-A 8 points). Sensitivity and specificity at these cut-off points fell into the acceptable 0.7 - 0.9 range.
CONCLUSION: On the basis of these results, HADS can be used as a reliable and valid instrument for the measurement and identification of anxiety and depression symptoms and disorders in cardiac patients.

Entities:  

Mesh:

Year:  2008        PMID: 19218625

Source DB:  PubMed          Journal:  Psychiatr Hung        ISSN: 0237-7896


  4 in total

Review 1.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

Review 2.  Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review.

Authors:  Brett D Thombs; Michelle Roseman; James C Coyne; Peter de Jonge; Vanessa C Delisle; Erin Arthurs; Brooke Levis; Roy C Ziegelstein
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

3.  Factors Predicting the Utilization of Center-Based Cardiac Rehabilitation Program.

Authors:  Lufei Young; Qi Zhang; Eric Lian; Kimberly Roberts; Neal Weintraub; Yanbin Dong; Haidong Zhu; Hongyan Xu; Pascha Schafer; Stephanie Dunlap
Journal:  Geriatrics (Basel)       Date:  2020-09-28

4.  Depression and Anxiety Are Associated with Physical Performance in Patients Undergoing Cardiac Rehabilitation: A Retrospective Observational Study.

Authors:  Maaya Sakamoto; Yasunori Suematsu; Yuiko Yano; Koji Kaino; Reiko Teshima; Takuro Matsuda; Masaomi Fujita; Rie Tazawa; Kanta Fujimi; Shin-Ichiro Miura
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.